UBS UK Equity Income C Acc
ISIN: GB00B4W58959 | MEX: 7PBAAT | CITI: G5QU
-
Buy 113.95 GBX
-
Sell 113.95 GBX
-
Price Change -0.04390%
Past Performance
- 29th Apr 2020 to 29th Apr 202136.97%
- 29th Apr 2021 to 29th Apr 202213.03%
- 29th Apr 2022 to 29th Apr 202313.79%
- 29th Apr 2023 to 29th Apr 20248.87%
- 29th Apr 2024 to 29th Apr 20253.37%
Objectives and Approach
The UBS UK Equity Income Fund (the "Fund") aims to generate income and grow the value of your investment; and outperform the FTSE All-Share Index the "Benchmark") after charges over the medium to long term (3 to 5 years). At least 80% of the Fund will be invested in shares of UK companies or non UK companies which are listed in the UK or which have significant trading activities in the UK. The Fund may also invest in other equities, bonds, warrants, money market instruments, deposits, currencies, cash and near cash and other funds, which may be managed by UBS. The Fund may use derivatives (financial instruments whose value is linked to an underlying asset or index) for investment purposes or efficient portfolio management. The Fund is actively managed, the strategy is to invest in equities believed to be undervalued by the market. Investors can buy or sell shares every UK working day. The income in respect of an accumulation share class is not distributed but is retained in the Fund and reflected in the share price. This Fund may not be appropriate for investors who plan to withdraw their money within 5 years of investment.
Key Information
Inception | 30th Mar 2007 |
Historic Yield | 4.5000% |
Sector | IA UK Equity Income |
Fund Size | £313.170mn |
Fund Type | OEIC |
Classification | Accumulation |
Charges
Total Ongoing Charges
Please note that whilst we endeavour to show all charges associated with specific funds, sometimes this is not possible due to the information not being made available by the fund provider. In such cases transaction or incidental cost information may be missing. |
0.7919% |
Initial Charge | 0% |
AMC | 0.50% |
Our Platform Charge We charge a platform fee of 0.30%. Our charges are shown on our rates and charges sheet |
0.30% |
Cost and Charges Information
This calculator provides you with costs and charges information regarding our charges and, where relevant, the costs within this investment product
Account Type
Annual charges
These are the annual costs based on an initial investment amount of over 1 year assuming a net zero growth rate
Cost Category | % of Investment | lump sum costs |
---|---|---|
Our annual fee
Our annual feeIncludes our platform fee at 0.30% per annum (excluding Charles Stanley Multi Asset Funds and anycash held). The min fee is £60, the max is £600 per annum, plus SIPP administration fee (if applicable, only charged if < £30,000 held) – see here |
0.30% | |
Dealing charges
Dealing chargesAny one-off commission charges associated with investing. Note that government taxes and levies are not included. This does not include any commission credits you may have available |
N/A | |
Product provider costs
Product provider costsProduct provider costs shown are inclusive of the fund ongoing charges figure (OCF), transaction costs and incidental costs |
0.7919% | |
Total (£)
Total (£)Costs per annum displayed in monetary value |
||
Total (%)
Total (%)Costs per annum displayed as a percentage of investment value |
Cumulative effect of charges on your investment's return
This illustration assumes that costs occur evenly throughout the year, charges are paid out of the investment evenly throughout the year, and that an annual growth rate of applies evenly throughout the year, before any charges including product charges
lump sum invested with an assumed growth rate of | 1 year | years |
---|---|---|
What you might get back at with no charges applied
What you might get back at with no charges appliedThese are the illustrative values of a investment after growth and no costs applied at the end of the defined period |
||
Annual charges
Annual chargesThese are the annual costs based on an initial investment amount of assuming a net zero growth rate |
||
Effect of charges on return (%)
Effect of charges on return (%)These are the overall costs in percentage terms, based on an initial investment amount of assuming a growth rate |
||
Effect of charges on return (£)
Effect of charges on return (£)These are the overall costs in monetary value, based on an initial investment amount of assuming a growth rate |
||
What you might get back at with charges applied
What you might get back at with charges appliedThese are the illustrative values of a investment after growth and costs at the end of the defined period |
This illustration is not a forecast of future investment performance but merely a means to demonstrate the potential impact of costs and charges for an assumed return of . Whilst we make reasonable endeavours to ensure the accuracy of third party charges information, this is intended for illustrative purposes only and should not be relied upon. We do not warrant or represent that this information is accurate, complete or up to date, therefore we accept no responsibility or liability for its use
Performance
-
Chart Options
Select TimeframeFromToAdd comparator to chartNone
This fund's IA Sector (IA UK Equity Income)
Another IA SectorSearch for Fund ComparatorAdd a FTSE Index
Current Comparators -
Cumulative Performance
1 month 3 months 6 months 1 year 3 years 5 years -5.28% -2.57% 1.66% 3.37% 28.05% 98.24%
Important Information
Headline performance can mask the true characteristics of a fund. Without fully understanding how a fund is managed, you may inadvertently become exposed to an undesirable level of risk to your capital. Some funds carry a dilution levy which reduces the number of units realised on any initial investment as an initial charge. If this fund carries such a levy it should be detailed in the Key Investor Information Document (KIID), which we must provide and you should read before investing.
The charts and performance data shown are supplied by an external data provider and may contain data that appears to precede the introduction of the clean unit class for this fund. In such cases, historical data has been synthesised at the entire discretion of that external provider as realistically as possible using historical data recorded against the previously available commission-paying version of the fund, adjusting for fees in the process.
Composition
View Fund Allocation by:
Important Documents
The documents listed below are the latest versions made available to our data provider by the fund management group, but may not necessarily reflect the applicable charges that would be levied should you purchase this fund via Charles Stanley Direct. You should treat the charges and other figures shown in the 'Overview' tab as accurate.
The Fact Sheet is supplied on a monthly basis by the management group and provides limited information on the fund. Past performance data and a review of how the fund has performed are commonly featured.
332,258 bytes PDF Document; last updated 28 Feb 2025
63,046 bytes PDF Document; last updated 18 Feb 2025
1,684,548 bytes PDF Document; last updated 31 Dec 2023
2,292,346 bytes PDF Document; last updated 30 Jun 2024
830,545 bytes PDF Document; last updated 06 Mar 2025
Management Team
Philip Haigh Kevin Barker Steven Magill
Philip Haigh
has managed this fund for 9 months.
There is currently no biography information for Philip Haigh.
Manager Cumulative Performance v Peer Group
All funds managed by Philip
Name of Security | Sole/Co | Managed Since |
---|---|---|
UBS UK Equity Income | Co | Jun 2023 |
Kevin Barker
has managed this fund for 3 years and 3 months.
There is currently no biography information for Kevin Barker.
Manager Cumulative Performance v Peer Group
All funds managed by Kevin
Name of Security | Sole/Co | Managed Since |
---|---|---|
UBS UK Equity Income | Co | Dec 2021 |
Steven Magill
has managed this fund for 12 years .
Steve Magill is head of the European Value team at UBS Asset Management, managing around $5 billion of UK equities and £2.4 billion of European equities. Magill initially joined UBS in 1986, before taking a career break to study. He re-joined after gaining a first class degree in accounting to UBS as a UK equity portfolio manager. Having successfully built a track record as a PM, Magill moved to a European healthcare role as a senior analyst, progressing rapidly to take on the role of deputy head of Pan-European Research in 2007 and leading the Global Healthcare team. Magill re-joined the UK Equity Value team in 2009 as part of a managed succession plan, becoming head of the team in 2015. In 2017 his responsibilities were extended to managing the European equity Value strategies. Magill is a regular member of the CFA Society of the UK and the CFA Institute.
Manager Cumulative Performance v Peer Group
All funds managed by Steven
Name of Security | Sole/Co | Managed Since |
---|---|---|
UBS UK Equity Income | Co | Apr 2013 |